![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2001, The National Academy of Sciences Microbiology A simple model host for identifying Gram-positive virulence factors *Department of Molecular Biology, ‡Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114; ¶Department of Medicine, Division of Infectious Diseases, ‖Department of Microbiology and Molecular Genetics, and **Center for the Study of Emerging and Re-Emerging Pathogens, University of Texas Medical School, Houston, TX 77030; and Departments of §Microbiology and Molecular Genetics and †Genetics, Harvard Medical School, Boston, MA 02115 ‡‡To whom reprint requests should be sent. E-mail: ausubel/at/frodo.mgh.harvard.edu. Contributed by Frederick M. Ausubel Accepted July 23, 2001. This article has been cited by other articles in PMC.Abstract We demonstrate the use of the nematode Caenorhabditis elegans as a facile and inexpensive model host for several Gram-positive human bacterial pathogens. Enterococcus faecalis, Streptococcus pneumoniae, and Staphylococcus aureus, but not Bacillus subtilis, Enterococcus faecium, or Streptococcus pyogenes, kill adult C. elegans. Focusing our studies on the enterococcal species, we found that both E. faecalis and E. faecium kill C. elegans eggs and hatchlings, although only E. faecalis kills the adults. In the case of adults, a low inoculum of E. faecalis grows to a high titer in the C. elegans intestine, resulting in a persistent infection that cannot be eradicated by prolonged feeding on E. faecium. Interestingly, a high titer of E. faecium also accumulates in the nematode gut, but does not affect the longevity of the worms. Two E. faecalis virulence-related factors that play an important role in mammalian models of infection, fsr, a putative quorum-sensing system, and cytolysin, are also important for nematode killing. We exploit the apparent parallels between Gram-positive infection in simple and more complex organisms by using the nematode to identify an E. faecalis virulence factor, ScrB, which is relevant to mammalian pathogenesis. Gram-positive pathogens in the genera Streptococcus, Staphylococcus, and Enterococcus are leading causes of human infections, causing diseases such as pneumonia, meningitis, bacteremia, endocarditis, and necrotizing fasciitis. The genus Enterococcus, the main focus of this article, is particularly problematic because of multidrug resistance, including resistance to vancomycin, often the antibiotic of last resort. Nevertheless, only a limited number of enterococcal virulence-related factors have been described, including cytolysin (Cyl), a factor called aggregation substance (AS), a zinc metalloprotease (gelatinase), and fsr, a putative quorum-sensing system thought to be involved in gelatinase and/or serine protease regulation (1–5). As the development of antibiotic resistance continues to erode one of the greatest advances in modern health care, it is crucial to identify bacterial targets that can form the basis of novel anti-infective therapies. One reason that relatively little is known about enterococcal virulence factors is that the mammalian models used to study enterococcal infections are cumbersome and expensive. Using a mammalian host to screen enterococcal mutant libraries for avirulent mutants, for example, would be prohibitively time consuming and expensive because of the large number of animals involved. Therefore, we have sought to develop alternative nonvertebrate hosts for Enterococcus and other Gram-positive human pathogens. Previously, our laboratory and others have shown not only that the Gram-negative human pathogens Pseudomonas aeruginosa and Salmonella enterica kill the nematode Caenorhabditis elegans, but also that P. aeruginosa and S. enterica virulence factors required for mammalian pathogenesis also are required for efficient killing of C. elegans (6–10). In this article, we demonstrate the suitability of using C. elegans as a model host for Gram-positive infection. We show that clinical isolates of Enterococcus faecalis, Streptococcus pneumoniae, and Staphylococcus aureus kill adult C. elegans, and that several features of the E. faecalis–C. elegans model that we have studied suggest that some aspects of human Gram-positive pathogenesis can be modeled successfully in a simple nonvertebrate host. Materials and Methods Assay of C. elegans Killing by Bacteria. Bacterial strains were grown on brain heart infusion (BHI) agar medium (Difco) in 35-mm tissue-culture plates (Falcon). Appropriate antibiotics were added to the medium to selectively prevent growth of Escherichia coli. Tetracycline (12.5 μg/ml) was used for E. faecalis strains E001, E002, E006, and E009 and for Enterococcus faecium strains E003 and E007. Gentamicin (25–50 μg/ml) was used for E. faecalis strains V583, OG1RF, and OG1X, and 5 μg/ml polymyxin B (American Research Products, Belmont, MA) was used for the experiment shown in Fig. Fig.11
C. elegans strain N2 was maintained and propagated on Escherichia coli strain OP50 with standard techniques (11). Between 20 and 30 C. elegans L4 or young adult hermaphrodites were transferred from a lawn of Escherichia coli OP50 to a lawn of the bacterium to be tested, incubated at 25°C, and examined at ≈24-hr intervals with a dissecting microscope for viability. Worms were considered dead when they did not respond to touch with a platinum wire pick. Each experimental condition was tested in duplicate or triplicate. Nematode survival was plotted with the Kaplan–Meier method using STATA 6 statistical software (Stata, College Station, TX). The same software was used for testing equality of survival (log-rank and Wilcoxon tests). P values of <0.05 were considered statistically significant. Measuring the Number of Bacteria Within the C. elegans Digestive Tract. Five C. elegans were picked at the times indicated in Fig. Fig.2,2
Microscopic Pictures of C. elegans. Nematodes were exposed for 3 days to bacteria on BHI plates and then placed on a pad of 2% agarose in a 5-μl drop of 30 mM NaN3 in M9 medium. The worms were examined at 100× magnification with an Axioplan2 microscope (Zeiss) with Nomarski optics. Screening for E. faecalis Tn917 Mutants Attenuated in Nematode Killing. A library consisting of ≈1,000 OG1RF Tn917 insertion mutants was constructed as described (12). The mutants were assayed for their ability to kill C. elegans as described above, except that only eight worms were placed on each lawn, and the number of live worms was determined only on days 2 and 6. Mutants that caused less than average killing were tested twice more with the standard assay to confirm the attenuated phenotype. Mouse Peritonitis Model. For the experiment shown in Fig. Fig.44
Results E. faecalis, Staphylococcus aureus, and Streptococcus pneumoniae Kill Adult C. elegans. We tested whether Gram-positive clinical isolates obtained from the Massachusetts General Hospital Clinical Laboratory could kill C. elegans as described in Materials and Methods. All strains of E. faecalis, S. aureus, and S. pneumoniae tested killed C. elegans. Representative data are shown in Fig. Fig.11 We studied the E. faecalis–C. elegans model in detail to investigate further the feasibility of using C. elegans as a model host for Gram-positive pathogens. We chose E. faecalis, in part, because we observed that both E. faecalis and E. faecium killed C. elegans' eggs and hatchlings in a manner that seems to be mechanistically distinct from the killing of the adult nematodes (data not shown). It was technically convenient that C. elegans failed to produce a brood on enterococcal lawns, as it was easier to keep track of the original adult nematodes. We used the previously studied E. faecalis isolates V583 (15) (recently sequenced and available at www.tigr.org) and OG1RF (16) for most of the following experiments because they killed C. elegans at approximately the same rate as the most virulent new isolates that were tested. A Small Initial Inoculum of E. faecalis Can Proliferate in the Nematode Gut. To determine whether a relatively small number of E. faecalis cells could kill C. elegans, we took advantage of the fact that E. faecium did not kill C. elegans under the conditions tested. L4 C. elegans were placed on mixed lawns of E. faecalis and E. faecium in ratios of 1:1, 1:102, 1:104, and 1:106. As shown in Fig. Fig.22 Surprisingly, as shown in Fig. Fig.22 To investigate the accumulation of E. faecium in the C. elegans intestine further, we carried out a transfer experiment with the E. faecium strains E003 and E007, which can be distinguished by their antibiotic resistance phenotypes, plated at an initial ratio of 1:103 E003 to E007 cells. When the worms on these plates were transferred to a lawn of only E007 cells, the ratio of E003 to E007 in the digestive tract never exceeded the initial ratio of 1:103 (Fig. (Fig.22 To confirm the observation of high titers of bacteria in the nematodes' intestines in the above experiments, we examined microscopically worms fed on Escherichia coli, B. subtilis, E. faecalis, and E. faecium lawns. As observed (6, 10), worms fed on Escherichia coli had no visible intact bacteria present in their intestinal lumen, and the lumen was slender in appearance (Fig. (Fig.33
Cyl Causes Faster Killing of C. elegans. E. faecalis has many naturally occurring conjugative plasmids, some of which encode a Cyl that lyses both eukaryotic and prokaryotic cells (17) and functions as a virulence factor in mouse models of endophthalmitis (5, 18) and peritonitis (2, 4). These plasmids also produce a cell surface protein called AS that promotes plasmid transfer (17) and also is thought to play a role in pathogenesis by mediating E. faecalis binding to host tissues (19). There is a significant increase in mortality in a rabbit model of endocarditis when both AS and Cyl are expressed (1). To determine whether Cyl or AS plays a role in C. elegans killing, we tested isogenic strains of E. faecalis OG1X (20) carrying mutant derivatives of pAD1 that encode both AS and Cyl. Plasmid pAM944 has a Tn917 disruption of the AS gene and is therefore Cyl+ AS−, whereas Tn917 disrupts the Cyl operon in pAM9058 (Cyl− AS+). pAM714 has a nondisruptive Tn917 insertion (Cyl+ AS+) (1) which was used as a control. As shown in Fig. Fig.44 A Deletion in fsrB Causes Attenuation in the Mouse and the Nematode. Previous work has shown that a disruption of E. faecalis gelE, which encodes gelatinase, causes attenuation of E. faecalis strain OG1RF in a mouse peritonitis model (4). Three genes located directly upstream of gelE—fsrA, fsrB, and fsrC—seem to be involved in gelE regulation. FsrA and FsrB are homologous to two component response regulators and sensor kinases (3), respectively, and a nonpolar fsrB deletion blocks the production of gelatinase (21). Based on the homology of FsrA, FsrB, and FsrC to the S. aureus quorum-sensing system encoded by agrA, agrB, and agrC, fsrB may encode a processor of a putative E. faecalis signal peptide (3). Fig. Fig.44 An Avirulent E. faecalis Mutant Identified by Using C. elegans Is Also Attenuated in the Mouse. In an attempt to identify previously unknown enterococcal virulence factors, we screened an E. faecalis transposon Tn917 library for mutants that were attenuated in killing nematodes. About 20 such mutants were identified, one of which, designated 1C-C9, was studied in further detail. When 1C-C9 was tested in the mouse i.p. infection model described above, the mice exhibited prolonged survival relative to the mice injected with parental strain OG1RF (P < 0.0104; Fig. Fig.44 Discussion Several Gram-negative human pathogens, including P. aeruginosa and S. enterica, have been shown to kill C. elegans when presented to the nematodes as a source of food (6–8, 10). In this article, we demonstrate that Gram-positive human pathogens including E. faecalis, S. aureus, and S. pneumoniae also kill C. elegans, and that E. faecium and S. pyogenes do not exhibit significant killing under the conditions tested. We do not understand why some human pathogens kill C. elegans whereas others do not. Initially, we thought that human pathogens able to infect and kill C. elegans would tend to be unspecialized, opportunistic species such as P. aeruginosa and E. faecalis. However, in this article, we show that S. pneumoniae, with an ecological niche thought to be limited to the human nasal-pharynx, also kills C. elegans. As illustrated in Fig. Fig.11 In the case of P. aeruginosa, two mechanistically distinct types of C. elegans killing have been identified in our laboratory. “Slow-killing” requires live bacteria and occurs when C. elegans are fed P. aeruginosa PA14 grown on low-osmolarity minimal medium (10). In contrast, “fast-killing” occurs on high-osmolarity medium, does not require live bacteria, and has been shown to be mediated by low molecular weight toxins (8). In the case of E. faecalis, secreted toxins are probably not the primary cause of killing adults, because antibiotic-treated E. faecalis did not kill (data not shown). With the exception of the P. aeruginosa toxin-mediated fast killing of worms, the mechanisms by which live P. aeruginosa, S. enterica, and E. faecalis kill worms is not clear. In all three cases, the worms do not appear to become rapidly paralyzed, as is the case in another P. aeruginosa–C. elegans model system involving P. aeruginosa strain PA01 (7). When C. elegans are feeding on Escherichia coli, essentially no live bacteria can be recovered from and no intact green fluorescent protein-labeled bacteria can be detected in the digestive system of the nematodes. In contrast, E. faecalis not only accumulates in the intestinal lumen, reaching steady-state titers as high as 105 cfu per worm (6, 10), but as shown in Fig. Fig.22 P. aeruginosa and S. enterica containing mutations in well known virulence factors such as lasR and phoPQ, respectively, are less virulent in C. elegans, validating the use of C. elegans to identify and study virulence factors relevant for mammalian pathogenesis (6, 10) In this article, we show that two known enterococcal virulence factors, Cyl and FsrB, which have been shown to enhance pathogenesis in various mammalian model systems, also enhance the rate at which C. elegans are killed by E. faecalis. Cyl disrupts membranes of both eukaryotic and prokaryotic cells (23) and is thought to increase tissue damage in mammalian models of endocarditis (1). fsrB putatively encodes a peptide processor necessary for quorum sensing (3). Polar mutations in fsrB previously have been shown to increase the survival time for i.p.-infected mice (3), and in this article we show that a nonpolar deletion in fsrB increases survival time in both the mouse and the nematode. In the C. elegans model, because noncytolytic E. faecalis and a fsrB deletion mutant are significantly attenuated but remain lethal (Fig. (Fig.4),4 In the case of P. aeruginosa strain PA14, we used TnphoA mutagenesis to identify killing-related factors by simply screening for PA14 mutants that exhibited a decreased rate of killing. This procedure resulted in the discovery of a variety of virulence factors that also are relevant for mouse pathogenesis (8, 9, 24). As shown in Fig. Fig.44 In contrast to Cyl, FsrB, and ScrB, E. faecalis AS seems to be a virulence factor only in mammalian infections. Because we have very little information concerning the mechanism by which E. faecalis (as well as P. aeruginosa and S. enterica) kill C. elegans, we do not understand why some virulence factors important for mammalian infection play a role in C. elegans killing, whereas others do not. Another factor that limits our mechanistic understanding of nematode–bacterial interactions is the lack of information concerning the C. elegans innate immune response. Although C. elegans seem to have homologs of some Toll signaling pathway components important to innate immunity in organisms as diverse as humans and Drosophila melanogaster, experiments to date have failed to demonstrate a significant role for the Toll pathway in a C. elegans defense response (27). We can hypothesize that shared virulence factors exert their effect by acting on conserved targets shared among diverse organisms. Conversely, virulence factors that have an effect in one species, but not in another, may be targeting factors specific to that species. Therefore, the use of C. elegans as a model host for mammalian pathogenesis likely will be limited to studying virulence factors involved in targeting evolutionarily conserved cellular mechanisms. In conclusion, we have shown that the clinically important Gram-positive pathogens E. faecalis, S. aureus, and S. pneumoniae kill adult C. elegans. Killing of adult C. elegans by E. faecalis has characteristics of an infectious process including colonization and proliferation of a small inoculum of bacteria. We show that two previously characterized enterococcal factors necessary for virulence in mammalian models, Cyl and FsrB, a protein that seems to be involved in quorum sensing, increase the rate of C. elegans killing. Finally, we provide evidence that C. elegans may be a useful model host for identifying novel Gram-positive virulence factors by showing that at least one E. faecalis mutation found in an initial screen for attenuation in C. elegans killing seems to prolong survival in a mouse model. Acknowledgments We thank D. B. Clewell, G. M. Dunny, M. S. Gilmore, W. Haas, and L. E. Hancock for generous gifts of strains and advice and M. S. Gilmore and A. Grossman for helpful comments about the manuscript. This work was supported by a grant from Aventis to Massachusetts General Hospital, by National Institutes of Health Grants AI42399 and AI47923 from the Division of Microbiology and Infectious Diseases and the National Institute of Allergy and Infectious Diseases (to B.E.M.), by a postdoctoral fellowship from the Irvington Institute for Immunological Research (to D.A.G.), and by postdoctoral fellowships from the Howard Hughes Medical Institute (to C.D.S. and E.M.). Abbreviations References 1. Chow J W, Thal L A, Perri M B, Vazquez J A, Donabedian S M, Clewell D B, Zervos M J. Antimicrob Agents Chemother. 1993;37:2474–2477. [PubMed] 2. Ike Y, Hashimoto H, Clewell D B. Infect Immun. 1984;45:528–530. [PubMed] 3. Qin X, Singh K V, Weinstock G M, Murray B E. Infect Immun. 2000;68:2579–2586. [PubMed] 4. Singh K V, Qin X, Weinstock G M, Murray B E. J Infect Dis. 1998;178:1416–1420. [PubMed] 5. Stevens S X, Jensen H G, Jett B D, Gilmore M S. Invest Ophthalmol Visual Sci. 1992;33:1650–1656. [PubMed] 6. Aballay A, Yorgey P, Ausubel F M. Curr Biol. 2000;10:1539–1542. [PubMed] 7. Darby C, Cosma C L, Thomas J H, Manoil C. Proc Natl Acad Sci USA. 1999;96:15202–15207. [PubMed] 8. Mahajan-Miklos S, Tan M W, Rahme L G, Ausubel F M. Cell. 1999;96:47–56. [PubMed] 9. Tan M W, Ausubel F M. Curr Opin Microbiol. 2000;3:29–34. [PubMed] 10. Tan M W, Mahajan-Miklos S, Ausubel F M. Proc Natl Acad Sci USA. 1999;96:715–720. [PubMed] 11. Sulston J, Hodgkin J. The Nematode Caenorhabditis elegans. Plainview, NY: Cold Spring Harbor Lab. Press; 1988. 12. Gutierrez J A, Crowley P J, Brown D P, Hillman J D, Youngman P, Bleiweis A S. J Bacteriol. 1996;178:4166–4175. [PubMed] 13. Chenoweth C E, Robinson K A, Schaberg D R. Antimicrob Agents Chemother. 1990;34:1800–1802. [PubMed] 14. Youngman P, Perkins J B, Losick R. Mol Gen Genet. 1984;195:424–433. [PubMed] 15. Sahm D F, Kissinger J, Gilmore M S, Murray P R, Mulder R, Solliday J, Clarke B. Antimicrob Agents Chemother. 1989;33:1588–1591. [PubMed] 16. Dunny G M, Brown B L, Clewell D B. Proc Natl Acad Sci USA. 1978;75:3479–3483. [PubMed] 17. Clewell D B. Cell. 1993;73:9–12. [PubMed] 18. Jett B D, Jensen H G, Nordquist R E, Gilmore M S. Infect Immun. 1992;60:2445–2452. [PubMed] 19. Kreft B, Marre R, Schramm U, Wirth R. Infect Immun. 1992;60:25–30. [PubMed] 20. Su Y A, Sulavik M C, He P, Makinen K K, Makinen P L, Fiedler S, Wirth R, Clewell D B. Infect Immun. 1991;59:415–420. [PubMed] 21. Qin X, Singh K V, Weinstock G M, Murray B E. J Bacteriol. 2001;183:3372–3382. [PubMed] 22. O'Toole G A, Pratt L A, Watnick P I, Newman D K, Weaver V B, Kolter R. Methods Enzymol. 1999;310:91–109. [PubMed] 23. Jett B D, Huycke M M, Gilmore M S. Clin Microbiol Rev. 1994;7:462–478. [PubMed] 24. Tan M W, Rahme L G, Sternberg J A, Tompkins R G, Ausubel F M. Proc Natl Acad Sci USA. 1999;96:2408–2413. [PubMed] 25. Loesche W J. Microbiol Rev. 1986;50:353–380. [PubMed] 26. Munro C L, Macrina F L. Mol Microbiol. 1993;8:133–142. [PubMed] 27. Pujol N, Link E M, Liu L X, Kurz C L, Alloing G, Tan M, Ray K P, Solari R, Johnson C D, Ewbank J J. Curr Biol. 2001;11:809–821. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Antimicrob Agents Chemother. 1993 Nov; 37(11):2474-7.
[Antimicrob Agents Chemother. 1993]Invest Ophthalmol Vis Sci. 1992 Apr; 33(5):1650-6.
[Invest Ophthalmol Vis Sci. 1992]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]J Bacteriol. 1996 Jul; 178(14):4166-75.
[J Bacteriol. 1996]J Infect Dis. 1998 Nov; 178(5):1416-20.
[J Infect Dis. 1998]Antimicrob Agents Chemother. 1990 Sep; 34(9):1800-2.
[Antimicrob Agents Chemother. 1990]Mol Gen Genet. 1984; 195(3):424-33.
[Mol Gen Genet. 1984]Antimicrob Agents Chemother. 1989 Sep; 33(9):1588-91.
[Antimicrob Agents Chemother. 1989]Proc Natl Acad Sci U S A. 1978 Jul; 75(7):3479-83.
[Proc Natl Acad Sci U S A. 1978]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Cell. 1993 Apr 9; 73(1):9-12.
[Cell. 1993]Invest Ophthalmol Vis Sci. 1992 Apr; 33(5):1650-6.
[Invest Ophthalmol Vis Sci. 1992]Infect Immun. 1992 Jun; 60(6):2445-52.
[Infect Immun. 1992]Infect Immun. 1984 Aug; 45(2):528-30.
[Infect Immun. 1984]J Infect Dis. 1998 Nov; 178(5):1416-20.
[J Infect Dis. 1998]Infect Immun. 1991 Jan; 59(1):415-20.
[Infect Immun. 1991]Antimicrob Agents Chemother. 1993 Nov; 37(11):2474-7.
[Antimicrob Agents Chemother. 1993]J Infect Dis. 1998 Nov; 178(5):1416-20.
[J Infect Dis. 1998]Infect Immun. 2000 May; 68(5):2579-86.
[Infect Immun. 2000]J Bacteriol. 2001 Jun; 183(11):3372-82.
[J Bacteriol. 2001]Methods Enzymol. 1999; 310():91-109.
[Methods Enzymol. 1999]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Cell. 1999 Jan 8; 96(1):47-56.
[Cell. 1999]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Cell. 1999 Jan 8; 96(1):47-56.
[Cell. 1999]Proc Natl Acad Sci U S A. 1999 Dec 21; 96(26):15202-7.
[Proc Natl Acad Sci U S A. 1999]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Curr Biol. 2000 Nov 30; 10(23):1539-42.
[Curr Biol. 2000]Proc Natl Acad Sci U S A. 1999 Jan 19; 96(2):715-20.
[Proc Natl Acad Sci U S A. 1999]Clin Microbiol Rev. 1994 Oct; 7(4):462-78.
[Clin Microbiol Rev. 1994]Antimicrob Agents Chemother. 1993 Nov; 37(11):2474-7.
[Antimicrob Agents Chemother. 1993]Infect Immun. 2000 May; 68(5):2579-86.
[Infect Immun. 2000]Cell. 1999 Jan 8; 96(1):47-56.
[Cell. 1999]Curr Opin Microbiol. 2000 Feb; 3(1):29-34.
[Curr Opin Microbiol. 2000]Proc Natl Acad Sci U S A. 1999 Mar 2; 96(5):2408-13.
[Proc Natl Acad Sci U S A. 1999]Microbiol Rev. 1986 Dec; 50(4):353-80.
[Microbiol Rev. 1986]Mol Microbiol. 1993 Apr; 8(1):133-42.
[Mol Microbiol. 1993]Curr Biol. 2001 Jun 5; 11(11):809-21.
[Curr Biol. 2001]